Cystatin C Tied to Worse Heart Failure Outcomes Across Ejection Fraction Spectrum

Follow Drugslib on

By Lori Solomon HealthDay Reporter

Medically reviewed by Carmen Pope, Senior Medical Editor, B. Pharm. Last updated on May 1, 2026.

via HealthDay

THURSDAY, April 30, 2026 -- Cystatin C (CysC) is an independent risk factor for adverse outcomes in patients with heart failure (HF) across the ejection fraction (EF) spectrum, according to a study published online April 20 in Clinical Cardiology.

Lyu Lyu, from the Capital Medical University in Beijing, and colleagues investigated the relationship between CysC and adverse outcomes in HF patients across the whole EF spectrum. The analysis included 637 HF patients with normal-to-mild renal insufficiency.

The researchers found that overall, there were significant associations between elevated CysC levels and increased risks for all-cause mortality and HF rehospitalization over 9.4 years of follow-up. The risk for all-cause mortality was higher for patients with midrange EF and reduced EF versus patients with preserved EF. CysC had less prognostic impact on all-cause mortality in patients with preserved EF. The addition of CysC to the MAGGIC risk score-based model had additional prognostic value for all patients, even with N-terminal pro-brain natriuretic peptide levels added.

"This research is the first to demonstrate a significant correlation between CysC levels and long-term outcomes across all hospitalized HF patient types with normal-to-mild renal dysfunction, backed by an extensive follow-up period," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-01 09:41

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords